Nicotine Replacement Therapies: Clinical Trials

4 trials of Nicotine Replacement Therapies, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed, 2 not yet recruiting. 2 Not applicable, 1 Phase 2, 1 Phase 4.

By phase and status

PhaseTrialsStatus
Not applicable2Completed 1, Not yet recruiting 1
Phase 21Completed 1
Phase 41Not yet recruiting 1

Follow Nicotine Replacement Therapies: new trials by email Literature Review of Nicotine Replacement Therapies trials Research Report on Nicotine Replacement Therapies

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Evaluation of the Efficacy of QUITOXIL® in Smoking Cessation
Quitoxil®, Nicotine Replacement Therapies - Tobacco Use Disorder
Not applicableNot yet recruitingKLAVA Innovation6062026-10-012026-07-24
Evaluation of Dependence and Nicotine Replacement Therapy-Supported Cessation Efforts Among Regular Electronic Cigarette Use
Nicotine Replacement Therapies, Brief Behavioral Counseling - E Cigarette Use, Cessation, Tobacco
Phase 4Not yet recruitingWest Virginia University1002026-09-012026-08-26
A Pilot Text Messaging Intervention to Reduce Smoking in Office-based Buprenorphine and Inpatient Detoxification Patients
Treatment As Usual (TAU), Nicotine Replacement Therapies, Text Message Intervention (TMI) - Smoking Cessation
Not applicableCompletedNYU Langone Health2032015-03-012017-12-06
Effectiveness of Various Smoking Cessation Therapies in Reducing Smoking in Adolescents - 1
Nicotine Replacement Therapies, Nicotine patch, Folic Acid - Smoking Cessation, Tobacco Use Disorder
Phase 2CompletedNational Institute on Drug Abuse (NIDA)1282002-04-012017-01-10

Conditions studied

Smoking Cessation (2)  ·  Tobacco Use Disorder (2)  ·  Opioid-Related Disorders (1)  ·  Smoking (1)  ·  Tobacco Use Cessation (1)  ·  Vaping (1)

Sponsors

KLAVA Innovation (1)  ·  NYU Langone Health (1)  ·  National Institute on Drug Abuse (NIDA) (1)  ·  West Virginia University (1)

Countries

United States (3)

Top investigators

Babak Tofighi, MD (1)  ·  Dorothy Hatsukami, Ph.D. (1)  ·  Eric E Soule, Ph.D (1)  ·  Melissa D Blank, Ph.D (1)

NIH funding

R15DA059750 (1)